Literature DB >> 6800874

Pathophysiologic and ultrastructural basis for intestinal symptoms in Fabry's disease.

B D O'Brien, T K Shnitka, R McDougall, K Walker, L Costopoulos, B Lentle, L Anholt, H Freeman, A B Thomson.   

Abstract

Fabry's disease is a rare, sex-linked disorder of glycolipid metabolism. We describe a patient with watery diarrhea, early satiety, and asymptomatic cholelithiasis. The jejunal aspirate demonstrated bacterial overgrowth; sigmoidoscopy showed rectal angiokeratoma corpora diffusum. The gastric emptying rate measured with 99mTc-sulfur colloid was markedly prolonged and the fasting gastrin was elevated at 276 pg/ml. The (14C)glycocholate breath test demonstrated a markedly elevated peak at 4 h, associated with an increased fecal bile acid loss of 0.82 g/day. Oral cholecystogram showed a solitary radiolucent stone in a functioning gallbladder. The bile acid pool size and lithogenic index were normal. Light microscopy of small bowel and rectal biopsy specimens revealed normal surface epithelium, but enlarged and vacuolated ganglion cells in Meissner's plexus. Electron microscopy showed laminated and amorphous osmiophilic deposits within ganglion cells of the submucosal plexus, within smooth muscle cells of the muscularis mucosae, and within endothelial cells lining arterioles, venules, and capillaries, but not in autonomic nerve fibers or enterocytes. The diarrhea and early satiety responded promptly to metoclopramide and to tetracycline. The early satiety was likely on the basis of delayed gastric emptying due to deposition of sphingolipid within ganglion cells of the autonomic nervous system; the diarrhea was likely on the basis of intestinal stasis with bacterial overgrowth and bile salt wastage.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6800874

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  18 in total

1.  Exocrine pancreatic insufficiency is not a cause of abdominal complaints in patients with Fabry disease.

Authors:  Miroslav Vujasinovic; Bojan Tepes; Bojan Vujkovac; Andreja Cokan Vujkovac; Martin Tretjak; Vesna Korat
Journal:  Wien Klin Wochenschr       Date:  2015-04-03       Impact factor: 1.704

Review 2.  Pearls and pitfalls in the diagnosis of adult celiac disease.

Authors:  H J Freeman
Journal:  Can J Gastroenterol       Date:  2008-03       Impact factor: 3.522

3.  Colonic involvement in Fabry's disease.

Authors:  C I Jack; A I Morris; D G Nasmyth; N Carroll
Journal:  Postgrad Med J       Date:  1991-06       Impact factor: 2.401

Review 4.  Macrophage-related diseases of the gut: a pathologist's perspective.

Authors:  Xavier Sagaert; Thomas Tousseyn; Gert De Hertogh; Karel Geboes
Journal:  Virchows Arch       Date:  2012-05-11       Impact factor: 4.064

5.  Gastrointestinal phenotype of fabry disease in a patient with pseudoobstruction syndrome.

Authors:  Piotr Buda; Anna Wieteska-Klimczak; Janusz Ksiazyk; Piotr Gietka; Anna Smorczewska-Kiljan; Maciej Pronicki; Barbara Czartoryska; Anna Tylki-Szymanska
Journal:  JIMD Rep       Date:  2011-11-04

Review 6.  Fabry disease: what the cardiologist should consider in non-cardiac screening, diagnosis, and management-narrative review.

Authors:  Claudia Regenbogen; Matthias Christoph Braunisch; Christoph Schmaderer; Uwe Heemann
Journal:  Cardiovasc Diagn Ther       Date:  2021-04

Review 7.  Fabry disease-often seen, rarely diagnosed.

Authors:  Björn Hoffmann; Ertan Mayatepek
Journal:  Dtsch Arztebl Int       Date:  2009-06-26       Impact factor: 5.594

8.  The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents.

Authors:  Markus Ries; Uma Ramaswami; Rossella Parini; Bengt Lindblad; Catharina Whybra; Ingrid Willers; Andreas Gal; Michael Beck
Journal:  Eur J Pediatr       Date:  2003-09-20       Impact factor: 3.183

Review 9.  Understanding the gastrointestinal manifestations of Fabry disease: promoting prompt diagnosis.

Authors:  Claire Zar-Kessler; Amel Karaa; Katherine Bustin Sims; Virginia Clarke; Braden Kuo
Journal:  Therap Adv Gastroenterol       Date:  2016-04-15       Impact factor: 4.409

Review 10.  Fabry disease in the era of enzyme replacement therapy: a renal perspective.

Authors:  Monique E Cho; Jeffrey B Kopp
Journal:  Pediatr Nephrol       Date:  2004-04-03       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.